The gene for the synaptic vesicle docking fusion protein, synaptosomal-associated protein of 25 kDa (SNAP-25), has been implicated in the etiology of attention-deficit hyperactivity disorder (ADHD) based on the mouse mutant strain coloboma. This neutron-irradiation induced mouse strain is hemizygous for the deletion of the SNAP-25 gene and displays spontaneous hyperactivity that is responsive to dextroamphetamine. Because of these characteristics, this strain has been suggested to be a mouse model for ADHD. We identified using single stranded conformational polymorphism analysis (SSCP) four DNA sequence variants in the 3Ј untranslated region of the human SNAP-25 gene. We searched for polymorphisms in the 3Ј untranslated region because the intron/exon structure of this gene has not yet been determined. We tested for linkage of this gene and ADHD using two of the identified polymorphisms that change a restriction enzyme recognition site. We examined the transmission of the alleles of each of these polymorphisms and the haplotypes of both polymorphisms using the transmission disequilibrium test in a sample of 97 small nuclear families consisting of a proband with ADHD, their parents, and affected siblings. We observed biased transmission of the haplotypes of the alleles of these two polymorphisms. Our findings are suggestive of a role of this gene in ADHD. Molecular Psychiatry (2000) 5, 405-409.
Introduction
SNAP-25 is an integral component of the vesicle docking and fusion machinery mediating regulated release of neurotransmitters (for review see Reference 1). 1 SNAP-25 is expressed in axonal growth cones during late stages of elongation and selective inhibition of SNAP-25 expression using antisense oligonucleotides prevents neurite elongation by rat cortical neurons. 2 High levels of expression in specific areas of the adult brain including regions of synaptic plasticity 3 suggest that SNAP-25 could contribute to axonal terminal remodeling, a process involved in cognitive functions. SNAP-25 is expressed in a subset of neuronal populations including those of the neocortex, hippocampus, anterior thalamic nuclei, pontine nuclei, and cerebellar granuale cells 3 and in other cells that perform regulated secretion such as insulin-producing pancreatic ␤-cells 4, 5 and chromaffin cells (neuroendocrine cells that undergo Ca 2+ -triggered exocytosis to release catecholamines). 6 The observations of the anatomical expression pattern of this gene and experimental manipulations using antisense oligonucleotides have implicated SNAP-25 in axonal growth and synaptic plasticity. 2 The SNAP-25 gene is within the deletion region in the coloboma mice mutant strain hemizygous for an approximately 2-cM deletion of mouse chromosome 2. These mice are characterized by several features most notably marked hyperactivity that begins between postnatal days 11-14. 8 Other characteristics include head bobbing, prominent eye dysmorphology, and paroxysmal circling activity. 9 Expression of a transgene encoding SNAP-25 rescues the hyperactivity but not the head bobbing or ophthalmic deformation 10 suggesting that the SNAP-25 gene is responsible for the observed hyperactivity but that the other characteristics of coloboma are the result of other genes in this deleted region. The coloboma strain is also delayed in some developmental milestones-the righting reflex and bar holding, a task designed to measure motor coordination. These delays are compensated over time such that the mice have comparable abilities to their normal litter mates at a later age. 8 Interestingly, d-amphetamine (2 or 4 mg kg −1 ) reduced locomotor activity in coloboma mice, but increased activity in control mice promoting comparisons to hyperactivity in children. However methylphenidate, a stimulant commonly used in the treatment of ADHD, increased locomotor activity in both coloboma and control mice at a dose of 2-32 mg kg −1 .
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The same dose of d-amphetamine that reduced locomotor activity in the coloboma mice, resulted in an increased activity comparable to wild type in the rescued mouse line with the transgene of SNAP-25, indicating that hyperlocomotion and the response to damphetamine is attributable to the SNAP-25 gene, 10 and argues for the role of this component of neurotransmitter release in the etiology of hyperlocomotion.
Raber et al 11 examined the release of specific neurotransmitters in vitro from synaptosomes and slices of selected brain regions of the coloboma mice compared to that of their wild-type litter mates. In an in vitro assay, both glutamate release from, and content in, synaptosomes prepared from neocortex of coloboma mice were reduced significantly compared to their wild-type litter mates. 11 The basal levels of dopamine and serotonin were unaffected, however, depolarization failed to induce dopamine release and induced significantly lower amounts of serotonin from dorsal striatum. The deficiency in dopamine and serotonin release was specific to the dorsal striatum. These results suggest that coloboma mice exhibit a region-specific and neurotransmitter-specific deficiency in neurotransmitter release and that the deficiency of glutamate, dopamine, and serotonin may be involved in hyperlocomotion.
The possibility that the SNAP-25 locus may be linked to ADHD was investigated by Hess and colleagues 12 using seven markers in the 20p11-p12 region, the region syntenic in humans to the mouse chromosome 2p. Five families where the pattern of inheritance appeared to be autosomal dominant were tested. No evidence for linkage was detected by the investigators, 12 however, their study had several limitations that may have precluded their ability to detect linkage. First, if there is significant locus heterogeneity for ADHD, five multi-generational families may not provide the power to detect this locus if by chance the majority of these families were not linked to the SNAP-25 locus. Second, only an autosomal dominant model was tested. Third, the linkage study of Hess et al 12 relied solely on the assumption that the SNAP-25 gene resides in the human region syntenic to mouse chromosome 2. The location of the SNAP-25 gene in the human genome has never been investigated and therefore this gene may not reside in the syntenic region. Because there were no polymorphisms available at the time of the study, the authors were not able to show that SNAP-25 is actually linked to the markers tested. It is possible that the SNAP-25 gene does not reside in this region of chromosome 20, however this is unlikely considering that there is complete synteny between mice and humans in this region. Also because the polymorphisms in the SNAP-25 gene had not been identified at the time of their study, the genetic distances among the markers chosen and the gene are unknown and the markers used may not have provided sufficient power to detect linkage in their sample.
In this study we address the limitations of the Hess et al 12 study by first identifying two polymorphisms in the SNAP-25 locus for our linkage studies. At the start of our study, the human genomic clone for SNAP-25 had not been isolated and therefore the intron/exon boundaries had not been determined for this gene. We therefore searched for polymorphisms in the region 3Ј to the coding region using the sequence of the cDNA clone (Genbank Accession Number D21267). Recently we have isolated the human genomic clone for SNAP-25 and we are currently sequencing this clone to determine the intron/exon structure of the gene.
We chose for our analysis a non-parametric test, the transmission disequilibrium test, 13 to avoid the uncertainty in the mode of inheritance. Furthermore, we tested for linkage using a sample of 97 nuclear families, an approach that is less sensitive to the effects of locus heterogeneity than linkage studies in a limited number of multi-generational families.
Methods

Diagnostic criteria
The assessment and characteristics of the subjects for this study have been described previously.
14 Briefly, subjects were included if they met the following DSM-IV criteria for ADHD: six symptoms of inattention and/or hyperactivity-impulsiveness either in the home or school setting as determined by clinical interview, evidence of pervasiveness defined as a minimum of four symptoms in the non-criterion setting, onset before 7 years of age. Exclusion criteria were subjects with scores below 80 on both the Performance and Verbal Scales of the WISC-III, 15 had evidence of neurological or chronic medical illness, bipolar affective disorder, psychotic symptoms, Tourette syndrome, or chronic multiple tics. Information for the diagnosis of ADHD and co-morbid conditions was based on a semistructured interview for parents (Parent Interview for Child Symptoms, PICS-IV; Schachar & Ickowicz, unpublished) and teachers (Teacher Telephone Interview-IV, TTI; Tannock & Schachar, unpublished), supplemented with the following questionnaires and child assessments: Conners Parent and Teacher Rating Scales-Revised, 16 the Ontario Child Health Survey Scales-Revised, 17 Wide Range Achievement Test-III, 18 Clinical Evaluation of Language Fundamentals, 3rd Edition, 19 Children's Depression Inventory, 20 and Children's Manifest Anxiety Scale. 21 Children were free of medication for a minimum of 24 h before their assessment. This protocol was approved by The Hospital for Sick Children (Toronto, Ontario) Research Ethics Board and informed written consent was obtained for all participants.
Subjects were aged between 7 and 16 years, recruited from referrals for clinical assessment of attention, behavior and learning problems to two clinics at an urban pediatrics hospital. The majority (96%) of families in this sample described themselves as mixed European Caucasian descent. The most common ethnic groups were English, Scottish, Irish, German, French, Italian, Polish, and Dutch. Five families described themselves as being of mixed or non-Caucasian descent. The Non-Caucasian ethnic groups consisted of African Canadians and Native Canadians.
Isolation of DNA, polymorphism detection, and marker genotyping DNA was extracted from blood lymphocytes using a high salt extraction method. 22 The 261-bp fragment of the 3Ј untranslated region was amplified with the following primers: SNAP-253ЈUTRF: ttc tcc tcc aaa tgc tgt cg and SNAP-253ЈUTRR: cca ccg agg aga gaa aat g, corresponding to bps 842-1103 of the cDNA sequence. 23 The conditions for the PCR were as follows: an initial denaturation step at 94°C for 4 min, followed by 35 cycles of 94°C for 30 s, 60°C for 40 s, and 72°C for 30 s. A final extension of 72°C was carried out for 10 min.
DNA sequence variants were identified using single strand conformational polymorphism (SSCP) analysis. 24 Two microliters (l) of PCR product were diluted in 24 l of SSCP loading dye (98% formamide, 0.1% SDS, 10 mM EDTA, 0.1% bromphenol blue, 0.1% xylene cyanole), and denatured at 95°C for 2 min. Samples were quick cooled on ice and electrophoresed at a constant voltage of 200 V on 4-20% TBE gels (Novex, La Jolla, CA, USA). The SSCP bands were visualized by silver staining. Gels were run at 20°C, 10°C or 4°C to increase the sensitivity to detect conformational polymorphisms. We cloned PCR products from individuals with bands with different mobilities using the TA cloning kit (Invitrogen, Carlsbad, CA, USA). After comparing the SSCP pattern of the clones with the SSCP pattern of the individual that the clones were derived from, we sequenced several clones with different mobilities.
For genotyping the two polymorphisms, five l of PCR product were digested with five units of either MnlI (New England Biolabs, Beverly, MA, USA) or DdeI (New England Biolabs). For allele 1 (T) of the MnlI digest, the 261-bp fragment was cut into two fragments of 256 and 5 bp but was not cut at the polymorphic restriction site. For allele 2 (G), the 261-bp fragment was cut into 210-, 46-, and 5-bp fragments. For the DdeI polymorphism, allele 1 (T) was not cut and for allele 2 (C) the fragment was cut into two fragments of 228 bp and 33 bp. The restriction enzyme fragments were electrophoresed on 3% agarose gels followed by ethidium bromide staining to detect the alleles.
Statistical analysis
Statistical analysis was performed using the ETDT program. 25 Linkage disequilibrium between the two markers was estimated with the EH program. 26 
Molecular Psychiatry
Results
By SSCP analysis we identified several different shifts in mobility of the 261-bp PCR fragment of the 3Ј untranslated region (see Figure 1) . We cloned and sequenced the PCR products from three different individuals. Sequence analysis of these clones revealed four different base pair changes from the published sequence, G1026A, G1038A, T1065G, and T1069C (nucleotide numbering according to Reference 23) . 23 Two of these sequence changes, T1065G and T1069C, result in a change in restriction enzyme recognition site and were further pursued. The T to G change at 1065 results in a gain of the MnlI restriction site and the T to C change at 1069 results in a gain of a DdeI restriction site.
For this study we genotyped DNA from 122 subjects diagnosed with ADHD. Sample sizes for the TDT statistic were lower, however, because a child is used only when one or both parents were heterozygous for the alleles or haplotypes. The children were either probands or affected siblings in families of different structures. Specifically, 83 families consisted of a proband and both parental DNAs genotyped and 14 families with a proband genotyped for a single parent. Haplotypes could be determined unambiguously in 66 of these families.
The allele frequencies in the parental chromosomes for the MnlI polymorphism (T1065G) were 0.663 for allele 1 (T, absence of the polymorphic restriction site) and 0.337 for allele 2 (G, presence of the restriction site). For the DdeI polymorphism (T1069C), the allele frequency was 0.772 for allele 1 (T, absence of the DdeI restriction site) and 0.228 for allele 2 (C, presence of the DdeI site).
The haplotype frequencies for the two polymorphisms were as follows: for the absence of the restriction sites at both polymorphisms, 0.438; for the absence of the restriction site at the MnlI site (T) and presence of the restriction site at DdeI (C), 0.228; for the presence of the restriction site at the MnlI site (G) and absence of the restriction site at DdelI (T), 0.334. The fourth possible haplotype, the presence of the restriction sites at both the MnlI and DdeI sites, was not seen in this sample of parental chromosomes.
Linkage disequilibrium between the genotypes of the two polymorphisms was examined using the EH program. 26 The EH program first estimates the allele frequencies for each marker assuming no allelic association. It then estimates the haplotype frequencies under the assumptions of no allelic association and allelic association. A chi-square and the number of degrees of freedom are calculated under the hypothesis of no allelic association and allelic association. We observed significant disequilibrium for the distribution of the genotypes ( 2 = 33.19, df =1, P Ͻ 0.000001). The finding of strong linkage disequilibrium is not surprising considering that the two polymorphisms are separated by three base pairs.
We tested for biased transmission of the alleles at each polymorphism and the haplotypes of the poly- Figure 1 The sequence of the 281-bp fragment of the 3Ј untranslated region of SNAP-25, located 16 nucleotides 3Ј to the stop codon at nucleotides 824-826 (Genbank Accession Number D21267. 23 The underlined nucleotides represent the sequence (or complementary sequence) of the primers (SNAP-253ЈUTRF and SNAP-253ЈUTRR) used to amplify this region. The nucleotides in bold represent the polymorphic nucleotides with the alternative nucleotide shown below. morphisms using the ETDT program. 25 The TDT test was not significant for either allele of the MnlI polymorphism (Table 1) . For the DdeI polymorphism, allele 2 (C, presence of the site) was transmitted 48 times compared to allele 1 (T, absence of the site) that was passed 32 times ( Table 2 ). The TDT chi-square showed a trend but not significant ( 2 = 3.2, 1 df, P = 0.074). For the haplotypes of these two polymorphisms, the haplotype of the absence of the site for the MnlI polymorphism (T, allele 1) and the presence of the DdeI site (C, allele 2) was significant ( 2 = 4.738, 1 df, P = 0.030; see Table 3 ).
Discussion
From this initial study, the biased transmission of the haplotypes of the SNAP-25 gene support the preexisting hypothesis that this gene may have a role in ADHD. The results of this study should however be considered preliminary in light of the significance level of these findings and that we have tested several other candidate genes on this sample. Previously we have reported in this sample a positive finding for the transmission of the 7-repeat allele of the exon III polymorphism in the dopamine D4 receptor gene. 27 At first glance we found it surprising that there was no evidence for biased transmission of alleles of the MnlI polymorphism given that the two polymorphisms are separated by 3 bp and are in strong linkage disequilibrium. By examination of the haplotypes it was evident that the combination of the common allele (allele 1, 0.633) of the MnlI polymorphism and the less common allele of the DdeI (allele 2, 0.228) was the haplotype transmitted more often to the probands. The increased information of the transmissions from the less common DdeI allele resulted in the separation of the 1 allele from the MnlI polymorphism into two haplotypes, one of which was preferentially transmitted to the probands and affected siblings. Our results using haplotypes accentuate the advantages of using several polymorphisms and the examination of haplotypes whenever more than one polymorphism is available for linkage studies.
Also important to note is the comparison of the transmission of allele 2 of the DdeI polymorphism and the only haplotype with the allele 2 of the DdeI poly-morphism. For the transmission of the haplotypes, when the total number of informative transmissions was decreased because the phase could not be unambiguously determined, the differential change in a single transmission (17 compared to 16) over the decreased number of total informative transmissions (61 vs 80) results in an increase in the 2 value from 3.200 to 4.738 and the concurrent change in the significance. This suggests that the results must be interpreted cautiously because with fewer transmissions a greater possibility of a spurious finding would exist.
At this point it is prudent to first confirm our linkage finding in an independent sample and then to identify additional polymorphisms and mutations in this gene for further studies. Of particular interest will be identification of functional polymorphisms in the coding regions and in regions controlling expression of this gene. The evidence from the mouse model would suggest that a mutation resulting in a loss of function or a reduction of expression of the gene would be expected as an etiologic factor in humans. To this end we have recently identified a genomic clone for SNAP-25 and are in the process of identifying the intron/exon boundaries so that we will be able to screen DNAs from our sample for additional DNA variants.
